Pharmacy Benefit Oversight & Compliance

Navigate State and Federal Requirements · Mitigate Fraud and Abuse · Ensure Stakeholder Compliance

Now in its 6th year, CBI’s Pharmacy Benefit Oversight & Compliance returns with robust content focusing on the complex legal and compliance nuances associated with managing pharmacy benefits.

Join your colleagues from health plans and PBMs to analyze the trends surrounding increased oversight and how companies are organizing their compliance programs to mitigate risk.

Key Topics to be Addressed:

Analyze how the 2016 presidential election impacts the industry and potential regulatory changes
Reduce opioid overutilization and reduce rates of high risk medications in the elderly
Examine changes in Part D
Update on Drug Enforcement Administration (DEA) prescriber guidance
Hear about increasing RAC audits
Prior-authorization expectations, forms and requirements
Best ways to manage cost, compliance and medication adherence
Trends in fraud and abuse and prescription drug monitoring programs
Update on the STARS program
CMS Auditing and monitoring
Challenges associated with specialty drugs and limited distribution models
HIPAA and HITECH — implications of increased privacy and security regulations and protections
Legal and compliance considerations for mail order pharmacy operations
Medicaid vs. Medicare differences and reporting requirements

Who Should Attend

You will benefit from attending this event if you are an executive, senior manager or director overseeing pharmacy benefits at a PBM, health plan, pharmacy or manufacturer with responsibilities or involvement in the following areas: